BioMarin Pharmaceutical | BMRN - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q1 Mar/2026 0.76 0.74 1.13 May/04
FY2025Q4 Dec/2025 0.46 0.77 0.92 Feb/23
FY2025Q3 Sep/2025 0.12 0.86 0.91 Oct/27
FY2025Q2 Jun/2025 1.44 0.84 0.96 Aug/04
FY2025Q1 Mar/2025 1.13 0.65 0.71 May/01




Eps Alterar Data
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Amgen USD 5.15 0.14 2026-03
Bayer EUR 2.71 2.09 2026-03
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
Incyte USD 1.81 0.01 2026-03
Insmed USD -0.76 0.78 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Moderna USD -3.4 1.29 2026-03
Neurocrine Biosciences USD 1.94 0.06 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 2.17 2.84 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
United Therapeutics USD 5.82 1.88 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03